Skip to content
Library/For Wet/Gonadorelin
FDA-approvedFor Wet+2 more

Gonadorelin

Synthetic gonadotropin-releasing hormone. We read all 60 studies. The protocol is below.

Updated 03 May 2026Read 13 minEvidence ●●●●○Citations 60

Free — puts Gonadorelin on your decision board.

The Gonadorelin Report · $19

Everything you need to start: dose, sourcing, safety, our verdict.

One purchase · yours forever

Built from 60 cited studies.

Status
FDA
Class
For Wet
Evidence
4/ 5●●●●○
Decades of clinical use
Read this if
  • you're on TRT and your clinic switched you from hCG to gonadorelin and didn't explain why
  • you're a Marek / Hone / Defy patient and want to know if your testicles are doing anything
  • you're trying to understand whether the half-life issue applies to you
  • **your TRT clinic dosed this 2× per week** — that's below the pulsatility threshold the HPG axis needs. Pulsatile GnRH (Belchetz 1978 PMID 691192) was 'every 60–90 minutes via pump,' not 'twice weekly bolus.' The 2×/week protocol is a marketing convenience that's pharmacologically closer to nothing than to the trial paradigm
Skip this if
  • you want fertility preservation and your clinic is dosing this twice a week — that's not enough
  • you have a pituitary tumor or other HPG-axis pathology that hasn't been worked up
  • you're not okay with daily-or-more injection frequency
First 90 days · Gonadorelin
Weeks 1–2
On-demand class — works in 30–60 min on the day of use or it doesn't. The PT-141 effect either shows up at the proper dose or it's the wrong molecule for you.
Weeks 4–8
Side-effect accumulation is the real watch-for: facial hyperpigmentation (MC1 receptor), nausea with repeated use, mood changes.
Week 12 — decide
Decide based on the on-demand response pattern, not a slow build-up. There is no slow build-up here.
Quit if
  • Facial or scalp hyperpigmentation that doesn't fade after stopping for 2–4 weeks.
  • Persistent nausea on repeated use.
  • Zero response to 2–3 attempts at proper dose (one of these — it's not for everyone).
Identity

What it is.

Gonadorelin is synthetic GnRH (gonadotropin-releasing hormone) — the 10-amino-acid hypothalamic that pulses every 60-90 minutes to drive LH and FSH release from the pituitary. It is the natural human sequence, manufactured synthetically.

It was historically as Factrel for diagnostic use (testing pituitary function) and for treating delayed puberty and hypothalamic infertility, though most of the clinical inventory has been discontinued in the US over the years. Lutrelef, a -pump form, is still used in some fertility settings internationally.

In the modern men's health and TRT world, gonadorelin has become popular as an alternative to hCG for maintaining testicular function and fertility during TRT. The pitch is that it works upstream of LH (asking the pituitary to make its own LH) rather than mimicking LH directly. The reality is that gonadorelin's natural is only about 2-4 minutes, which makes the pharmacology much harder than hCG's.

TL;DR

TL;DR. 30-second version.

The compressed verdict — what Gonadorelin actually is, what the human evidence shows, and the watch-for in three bullets. Locked.

Get the report · $19
Mechanism

Mechanism.

Mechanism · in the Gonadorelin report

How the molecule actually works — receptor profile, downstream signaling, what to expect mechanistically.

Get the report · $19
Evidence

Evidence. What we actually know in humans.

Evidence · in the Gonadorelin report

The trial breakdown — phase, n, primary endpoint, who funded, what hit, what didn't.

Get the report · $19
Human-Evidence Factbox
Decades of clinical use
$19
TRT clinic adoption
$19
Pulsatile dosing = stimulates LH/FSH
$19
Continuous dosing = SHUTS DOWN LH/FSH
$19
Clinic protocol — testicular preservation
$19
Clinic protocol — fertility induction (HH men)
$19
Clinic protocol — 2×/week (TRT)
$19
Major adverse events flagged
$19
Dose

Dose. The actual protocol.

Dose · in the Gonadorelin report

The specific protocol — dose, titration schedule, cycle pattern, frequency, route.

We read 60 studies to write this report.
Get the report · $19
Sourcing

Sourcing. Where the cohort actually buys.

Sourcing · in the Gonadorelin report

Sourcing breakdown — vendor methodology, red flags, our published test results, COA checklist.

We read 60 studies to write this report.
Get the report · $19
Safety

Safety. Side effects.

Safety · in the Gonadorelin report

The watch-for list — contraindications, drug interactions, monitoring labs, when to stop.

Get the report · $19
Editorial Position

Editorial position.

Editorial Position · in the Gonadorelin report

Our editorial position — explicit yes / no / depends, with the reasoning behind it.

Get the report · $19
Citations

Citations.

  1. 01Gillies PS, et al. Ganirelix. Drugs. 2000;59(1):107-11; discussion 112-3. PMID: 10718102.
  2. 02Torrini F, et al. Advances and perspectives in the analytical technology for small peptide hormones analysis: A glimpse to gonadorelin. Journal of pharmaceutical and biomedical analysis. 2023;228:115312. PMID: 36858006.
  3. 03Hashimoto T, et al. Gonadorelin and erythropoiesis. Archives of internal medicine. 1981;141(2):267. PMID: 7006547.
  4. 04Devroey P. GnRH antagonists. Fertility and sterility. 2000;73(1):15-7. PMID: 10632404.
  5. 05 Gonadorelin--synthetic LH-RH. The Medical letter on drugs and therapeutics. 1983;25(649):106-7. PMID: 6358816.
+Show all 60 citations
  1. 06Bouchard P. [Gonadorelin antagonists: present and future ]. La Revue du praticien. 2005;Spec. No:25-7. PMID: 15822867.
  2. 07Zhang L, et al. The Pulsatile Gonadorelin Pump Induces Earlier Spermatogenesis Than Cyclical Gonadotropin Therapy in Congenital Hypogonadotropic Hypogonadism Men. American journal of men's health. 2019;13(1):1557988318818280. PMID: 30569789.
  3. 08Melo DB, et al. Effect of 200 μg of gonadorelin hydrochloride at the first GnRH of a CO-Synch program on ovulation rate and pregnancies per artificial insemination in Holstein heifers. Journal of dairy science. 2024;107(8):6268-6277. PMID: 38460874.
  4. 09Hashem NM, et al. Reproductive performance of goats treated with free gonadorelin or nanoconjugated gonadorelin at estrus. Domestic animal endocrinology. 2020;71:106390. PMID: 31731249.
  5. 10Leão IMR, et al. Effect of 200 µg of gonadorelin at the first gonadotropin-releasing hormone of the Resynch-25 on ovarian dynamics and fertility in lactating Holstein cows. Journal of dairy science. 2024;107(5):3319-3334. PMID: 38101731.
  6. 11Shao WM, et al. [Micropump infusion of gonadorelin in the treatment of hypogonadotropic hypogonadism in patients with pituitary stalk interruption syndrome: cases analysis and literature review]. Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences. 2014;46(4):642-5. PMID: 25131486.
  7. 12Pace JN, et al. GnRH agonists: gonadorelin, leuprolide and nafarelin. American family physician. 1991;44(5):1777-82. PMID: 1835275.
  8. 13Yen SS. Gonadotropin-releasing hormone. Annual review of medicine. 1975;26:403-17. PMID: 167651.
  9. 14Jin XH, et al. [Research progress in immune regulation of gonadorelin]. Sheng li ke xue jin zhan [Progress in physiology]. 2000;31(2):169-72. PMID: 12545741.
  10. 15Valdés-Arciniega TJ, et al. Effect of using 200 μg of gonadorelin at the first gonadotropin-releasing hormone of the breeding-Ovsynch on ovulatory response and pregnancies per artificial insemination in first-service lactating Holstein cows. Journal of dairy science. 2023;106(12):9718-9732. PMID: 37641336.
  11. 16Osuga Y. [Endometriosis]. Nihon rinsho. Japanese journal of clinical medicine. 2006;64 Suppl 4:112-5. PMID: 16689294.
  12. 17Ferré-Dolcet L, et al. Disappearance of signs of heat and induction of ovulation in oestrous queens with gonadorelin: a clinical study. Journal of feline medicine and surgery. 2021;23(4):344-350. PMID: 32840446.
  13. 18Kesler DJ, et al. Gonadorelin-induced testosterone release: a biological assay for quality assurance of gonadorelin in veterinary medicine. Drug development and industrial pharmacy. 1999;25(3):315-21. PMID: 10071824.
  14. 19Janakiram NB, et al. Raloxifene and antiestrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem-like cells. Cancer prevention research (Philadelphia, Pa.). 2014;7(3):300-9. PMID: 24431404.
  15. 20Torrini F, et al. A biomimetic enzyme-linked immunosorbent assay (BELISA) for the analysis of gonadorelin by using molecularly imprinted polymer-coated microplates. Analytical and bioanalytical chemistry. 2022;414(18):5423-5434. PMID: 35028691.
  16. 21Bernardes Júnior JJ, et al. Gonadorelin increases semen production and does not affect its quality in Leporinus obtusidens. Animal reproduction science. 2017;185:154-160. PMID: 28847639.
  17. 22Hoitink MA, et al. Degradation kinetics of gonadorelin in aqueous solution. Journal of pharmaceutical sciences. 1996;85(10):1053-9. PMID: 8897270.
  18. 23Leão IMR, et al. Effect of gonadorelin dose and an additional gonadorelin treatment 2 days after the initiation of Resynch-25 on ovarian dynamics and fertility of lactating Holstein cows. Journal of dairy science. 2025;108(3):2914-2932. PMID: 39603499.
  19. 24Oliveira RGS, et al. Effects of gonadorelin on gonadotropin expression, plasma sex steroid concentrations and ovarian follicle dynamics in mature tambaqui (Colossoma macropomum). Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology. 2025;279:111126. PMID: 40645558.
  20. 25Zhao W, et al. [Effects of neuropeptides and neurotransmitters on the regulation of gonadorelin neurons endings in hypothalamic median eminence]. Sheng li ke xue jin zhan [Progress in physiology]. 1991;22(3):235-9. PMID: 1682999.
  21. 26Jiang YJ, et al. [Simplified gonadorelin stimulation test in diagnosis of precocious puberty]. Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences. 2004;33(5):452-5. PMID: 15476332.
  22. 27Akın O, et al. Anaphylaxis to gonadorelin acetate in a girl with central precocious puberty. Journal of pediatric endocrinology & metabolism : JPEM. 2015;28(11-12):1387-9. PMID: 26197466.
  23. 28Picard-Hagen N, et al. Effect of gonadorelin, lecirelin, and buserelin on LH surge, ovulation, and progesterone in cattle. Theriogenology. 2015;84(2):177-83. PMID: 25890780.
  24. 29Yordanova Y, et al. Zn(2+)-triggered self-assembly of Gonadorelin [6-D-Phe] to produce nanostructures and fibrils. Scientific reports. 2018;8(1):11280. PMID: 30050082.
  25. 30Fu JF, et al. Impact of BMI on gonadorelin-stimulated LH peak in premenarcheal girls with idiopathic central precocious puberty. Obesity (Silver Spring, Md.). 2015;23(3):637-43. PMID: 25645648.
  26. 31Poock SE, et al. Effect of different gonadorelin (GnRH) products used for the first or resynchronized timed artificial insemination on pregnancy rates in postpartum dairy cows. Theriogenology. 2015;84(4):504-8. PMID: 25979657.
  27. 32Rodrigues WB, et al. Timed artificial insemination plus heat II: gonadorelin injection in cows with low estrus expression scores increased pregnancy in progesterone/estradiol-based protocol. Animal : an international journal of animal bioscience. 2019;13(10):2313-2318. PMID: 30915942.
  28. 33Hoitink MA, et al. Degradation kinetics of three gonadorelin analogues: developing a method for calculating epimerization parameters. Pharmaceutical research. 1998;15(9):1449-55. PMID: 9755899.
  29. 34 Gonadorelin for induction of ovulation. The Medical letter on drugs and therapeutics. 1990;32(823):70-1. PMID: 2196417.
  30. 35Martínez M, et al. The effects of 3 gonadorelin products on luteinizing hormone release, ovulation, and follicular wave emergence in cattle. The Canadian veterinary journal = La revue veterinaire canadienne. 2003;44(2):125-31. PMID: 12650040.
  31. 36Traub-Hoffmann K, et al. Spray congealed solid lipid microparticles as a sustained release delivery system for Gonadorelin [6-D-Phe]: Production, optimization and in vitro release behavior. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. 2020;154:18-32. PMID: 32599272.
  32. 37Zhou XP, et al. Modulatory effects of gonadorelin on GABA-induced depolarization and GABA-activated current in rat spinal ganglion neurons. Zhongguo yao li xue bao = Acta pharmacologica Sinica. 1996;17(1):31-4. PMID: 8737448.
  33. 38Charbonnel B, et al. [GnRh antagonists]. Contraception, fertilite, sexualite (1992). 1993;21(1):13-21. PMID: 7951588.
  34. 39Yano T, et al. [GnRH antagonist]. Nihon rinsho. Japanese journal of clinical medicine. 2001;59 Suppl 1:133-8. PMID: 11235152.
  35. 40Helm VJ, et al. Stability of gonadorelin and triptorelin in aqueous solution. Pharmaceutical research. 1990;7(12):1253-6. PMID: 2151342.
  36. 41Crowley WF. The developmental biology of the GnRH neurons. Molecular and cellular endocrinology. 2011;346(1-2):1-3. PMID: 21741438.
  37. 42Paulson RJ. At last, an orally active gonadotropin-releasing hormone antagonist. Fertility and sterility. 2019;111(1):30-31. PMID: 30611410.
  38. 43Freick M, et al. [Use of gonadorelin[6-D-Phe] at day 0 or 12 after insemination to increase the conception rate in a large dairy herd in Saxony/Germany]. Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere. 2014;42(6):331-42. PMID: 25401927.
  39. 44Dolińska B, et al. Bioavailability of buserelin and gonadorelin in suspensions. Bollettino chimico farmaceutico. 1995;134(8):459-60. PMID: 7576445.
  40. 45Jansen RP, et al. GnRH analogues in reproductive medicine. The Medical journal of Australia. 1991;154(9):571-2. PMID: 2056937.
  41. 46Buckingham JC, et al. Biological assay of luteinizing hormone-releasing hormone (gonadorelin). Journal of pharmacological methods. 1983;9(4):239-47. PMID: 6353073.
  42. 47Kawakami M. [Brain peptide hormones]. Horumon to rinsho. Clinical endocrinology. 1979;27(2):121-6. PMID: 106994.
  43. 48Saito S, et al. [LH-RH (author's transl)]. Nihon rinsho. Japanese journal of clinical medicine. 1978;36(1):130-5. PMID: 24760.
  44. 49Silva M, et al. A comparative study of the effects of intramuscular administration of gonadorelin, mating and intrauterine infusion of either raw seminal plasma or seminal plasma purified β-NGF on luteal development in llamas. Reproduction in domestic animals = Zuchthygiene. 2017;52(4):625-631. PMID: 28332278.
  45. 50Rastegarnia A, et al. The effect of different doses of gonadorelin on ovarian follicle dynamics in river buffalo (Bubalus bubalis). Theriogenology. 2004;62(7):1283-91. PMID: 15325555.
  46. 51Souza AH, et al. Comparison of gonadorelin products in lactating dairy cows: efficacy based on induction of ovulation of an accessory follicle and circulating luteinizing hormone profiles. Theriogenology. 2009;72(2):271-9. PMID: 19394072.
  47. 52Miyake H, et al. [LH-RH derivative]. Nihon rinsho. Japanese journal of clinical medicine. 2015;73 Suppl 2:313-6. PMID: 25831774.
  48. 53Beretta G, et al. [Intranasal gonadorelin in the treatment of cryptorchism]. Archivio italiano di urologia, nefrologia, andrologia : organo ufficiale dell'Associazione per la ricerca in urologia = Urological, nephrological, and andrological sciences. 1989;61(3):333-5. PMID: 2572057.
  49. 54Tanizawa O, et al. [LH-RH and analogues]. Nihon rinsho. Japanese journal of clinical medicine. 1981;39(9):2928-32. PMID: 6279922.
  50. 55Ayanie TD, et al. Ovarian response and conception rate in Boran and Boran*Holstein cows treated by Gonadotrophin-realizing hormone and ProstaglandinF2α with and without exogenous progesterone. BMC veterinary research. 2023;19(1):75. PMID: 37264362.
  51. 56Raehs SC, et al. The adjuvant effect of bacitracin on nasal absorption of gonadorelin and buserelin in rats. Pharmaceutical research. 1988;5(11):689-93. PMID: 3150047.
  52. 57Hoogeveen JH, et al. [Side effects of treatment with the long-acting gonadorelin agonist triptorelin in a case of paraphilia]. Tijdschrift voor psychiatrie. 2007;49(2):111-5. PMID: 17290340.
  53. 58Shanehsazzadeh S, et al. Estimation of human effective absorbed dose of 67Ga-cDTPA-gonadorelin based on biodistribution rat data. Nuclear medicine communications. 2011;32(1):37-43. PMID: 21068688.
  54. 59Kadrnka-Lovrencić M, et al. [Comparative clinico-therapeutic study of gonadorelin and chorionic gonadotropin in boys with undescended testes]. Lijecnicki vjesnik. 1987;109(2-3):90-2. PMID: 2885699.
  55. 60Storring PL, et al. The International Reference Preparation of Gonadorelin for Bioassay: a comparison with different preparations of synthetic luteinizing hormone releasing hormone using physicochemical methods of analysis, different bioassays and immunoassay. The Journal of endocrinology. 1982;95(1):95-103. PMID: 6752326.
The Gonadorelin Report · $19

Everything you need to start.

Dose, sourcing, safety, our verdict. One purchase. Yours forever.

Built from 60 cited studies.

Or get every report. All reports — $99 once · Pro — $29/mo.
Compare tiers →